Serum markers measured early in pregnancy have been associated with the later diagnosis of gestational diabetes mellitus (GDM). This study aims to explore the performance of a panel of first-trimester biochemical markers for the prediction of GDM.
Methods:
A case–control study was performed that included 12 women who developed GDM and 60 controls matched for maternal and gestational age at blood collection. Levels of pregnancy-associated plasma protein A (PAPP-A), soluble endoglin, pregnancy protein 13, and adiponectin (Adipo) were measured on residual sera used in first-trimester screening for Down syndrome. Data were analyzed by nonparametric methods. A receiver operating characteristic curve was used to calculate the detection rate (DR) obtained with a panel of significant predictors for GDM.
Results:
Multiples of the median values for Adipo and PAPP-A were significantly reduced in GDM cases versus matched controls. Combination of Adipo and PAPP-A yielded a DR of 63.6% at a false-positive rate of 10%. Addition of body mass index (BMI) to this panel increased DR to 72.7%.
Conclusion:
This study suggests that first-trimester screening with Adipo, PAPP-A, and BMI may effectively identify women at high risk for the development of GDM.
MetzgerBECoustanDR. Summary and recommendations of the Fourth International Workshop Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(suppl 2):B161–B167.
2.
Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol. 2013;122(2 pt 1):406–416.
3.
American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 20021;25(suppl 1):s90–s93.
4.
DonovanLHartlingLMuiseMGuthrieAVandermeerBDrydenDM. Screening tests for gestational diabetes: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2013;159(2):115–122.
5.
SolomonCGWillettWCCareyVJ. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278(13):1078–1083.
SacksDAHaddenDRMareshM; HAPO Study Cooperative Research Group. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Diabetes Care. 2012;35(3):526–528.
8.
AthukoralaCCrowtherCAWillsonK; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Women with gestational diabetes mellitus in the ACHOIS trial: risk factors for shoulder dystocia. Aust N Z J Obstet Gynecol. 2007;47(1):37–41.
9.
JoffeGMEsterlitzJRLevineRG. The relationship between abnormal glucose tolerance and hypotensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1998;179(4):1032–1037.
10.
van HoornJDekkerGJeffriesB. Gestational diabetes versus obesity as risk factors for pregnancy-induced hypertensive disorders and fetal macrosomia. Aust N Z J Obstet Gynecol. 2002;42(1):29–34.
11.
FeigDSZinmanBWangXHuxJE. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. Can Med Assoc J. 2008;179(3):229–234.
12.
EleftheriadesMPapastefanouILambrinoudakiI. Elevated placental growth factor concentrations at 11-14 weeks of gestation to predict gestational diabetes mellitus. Metabolism. 2014;63(11):1419–1425.
13.
NandaSSavvidouMSyngelakiAAkolekarRNicolaidesKH. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn. 2011;31(2):135–141.
14.
SyngelakiAKotechaRPastidesA. First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus. Metabolism. 2015;64(11):1485–1489.
15.
vanLeeuwenOpmeerBCZweersEJK. Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. BJOG. 2010;117(1):69–75.
16.
WilliamsMAQiuCMuy-RiveraM. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89(5):2306–2311
17.
LainKYDaftaryARNessRBRobertsJM. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol. 2008;69(3):407–411.
18.
GeorgiouHMLappasMGeorgiouGM. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol. 2008;45(3):157e65.
19.
SpencerKCowansNJ. The association between gestational diabetes mellitus and first trimester aneuploidy screening markers. Ann Clin Biochem. 2013;50(pt 6): 603–610.
20.
LovatiEBeneventiFSimonettaM. Gestational diabetes mellitus: including serum pregnancy-associated plasma protein-A testing in the clinical management of primiparous women? A case-control study. Diabetes Res Clin Pract. 20136;100(3):340–347.
21.
UnverdorbenLHüttenbrennerRKnablJJeschkeUHutterS. Galectin-13/PP-13 expression in term placentas of gestational diabetes mellitus pregnancies. Placenta. 2015;36(2):191–198.
22.
LappasM. Markers of endothelial cell dysfunction are increased in human omental adipose tissue from women with pre-existing maternal obesity and gestational diabetes. Metabolism. 2014;63(6):860–873.
23.
ZornTMZúñigaMMadridE. Maternal diabetes affects cell proliferation in developing rat placenta. Histol Histopathol. 2011;26(8):1049–1056.
24.
BenirschkeKKaufmannPBaergenRN. Pathology of the Human Placenta. 5th ed. New York: Springer; 2006.
25.
KirkegaardIUldbjergNOxvigC. Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview. Acta Obstet Gynecol Scand. 2010;89(9):1118–1125.
26.
LiSShinHJDingELvan DamRM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–188.
27.
KnowlerWCBarrett-ConnorEFowlerSE. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
28.
LuotoRLaitinenKNermesM. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr. 2010;103(12):1792–1799.
